
A Missouri state judge has granted final approval to a $7.25bn settlement that resolves thousands of lawsuits alleging that Bayer’s weedkiller Roundup causes cancer. The decision marks a decisive milestone for the German chemical company, which has faced significant legal pressure for nearly a decade over the safety of the product and its active ingredient, glyphosate.
Judge Timothy Boyer of a St Louis court determined that the proposed agreement was fair, reasonable and adequate. He rejected objections from some claimants who argued that the individual payouts were insufficient compared to amounts paid in previous settlements. The judge noted that further delays could force victims, including those with terminal illnesses, to wait an indeterminate number of years to receive compensation. The settlement, which was initially announced in February, is designed to resolve nearly all current and future Roundup claims in the United States.
Bayer had faced approximately 65,000 claims in US state and federal courts from individuals who said they developed cancer after using the herbicide at home or in the workplace. Bill Anderson, the company’s chief executive, described the court’s final approval as a key step in mitigating the risks associated with pending and future litigation. The legal battles have had a substantial impact on the firm’s market position, with its share price falling by 46 per cent since it acquired Monsanto, the producer of Roundup, for $63bn in 2018.
This latest approval follows a significant legal development in which the US Supreme Court overturned a $1.25m jury award for a Missouri man who blamed his non-Hodgkin lymphoma on exposure to glyphosate. In a 7-2 decision, the court agreed with Bayer that federal pesticide regulations barred certain failure-to-warn claims brought under state law. While this ruling narrowed the ability of some victims to pursue claims in court, Christopher Seeger, a lawyer representing many plaintiffs, stated that the group looks forward to distributing the relief to victims as quickly as possible.
Bayer has consistently maintained that Roundup is safe, citing decades of studies showing that glyphosate does not cause cancer. The company previously settled much of the litigation for $10.9bn in 2020 but was unable to secure court approval for a separate $1.25bn settlement for future claims. The current agreement excludes some lawsuits that remain pending in federal court, with Bayer noting that approximately 200 of those cases are still being litigated.
The following content has been published by Stockmark.IT. All information utilised in the creation of this communication has been gathered from publicly available sources that we consider reliable. Nevertheless, we cannot guarantee the accuracy or completeness of this communication.
This communication is intended solely for informational purposes and should not be construed as an offer, recommendation, solicitation, inducement, or invitation by or on behalf of the Company or any affiliates to engage in any investment activities. The opinions and views expressed by the authors are their own and do not necessarily reflect those of the Company, its affiliates, or any other third party.
The services and products mentioned in this communication may not be suitable for all recipients, by continuing to read this website and its content you agree to the terms of this disclaimer.